Loading ...
coronavirus ( COVID-19 ) in ... Mar 5 , 2020(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
coronavirus ( COVID-19 ) in the U.S. , Australia , China and Europe(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
coronavirus ( COVID-19 ) in the United States , Australia , China and Europe(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
coronavirus ( COVID-19 ) GALWAY , Ireland , April 8 , 2020(passive) caused bypatients with Acute Respiratory Distress Syndrome ( ARDS
coronavirus ( COVID-19 ) View source version on businesswire.com(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
coronavirus ( COVID-19 ) Lattice Biologics Ltd. ( TSX - V : LBL ) ( OTCQB : LBLTF(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
COVID-19 ( AKA viral pneumonia(passive) caused bypatients with Acute Respiratory Distress Syndrome
COVID-19 in the US , Australia , China and Europe(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
COVID-19 in the U.S , Australia , China and Europe 1(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
Mauro R Tucci , Eduardo L V Costa , Maria A M Nakamura , Caio C A Morais Noninvasive ventilation ( NIV ) is commonly usedto preventendotracheal intubation in patients with acute respiratory distress syndrome ( ARDS
sepsis(passive) caused bypatients with Acute Respiratory Distress Syndrome
severe acute respiratory syndrome ( SARS(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
acute phosgene poisoning(passive) caused bysevere patients with acute respiratory distress syndrome ( ARDS
the SARS - CoV-2 virus(passive) caused bypatients with Acute Respiratory Distress Syndrome ( ARDS
IMPORTANCE Noninvasive ventilation ( NIV ) with a face mask is relatively ineffective at Video at jama.compreventingendotracheal intubation in patients with acute respiratory distress syndrome ( ARDS
coronav(passive) caused bypatients with acute respiratory distress syndrome ( ARDS
The scientific community is currently examining the usefulness of immunomodulatory moleculesto preventacute respiratory distress syndrome in patients with COVID-19
blastomycosis(passive) caused bypatients with Acute Respiratory Distress Syndrome ( ARDS
from H1N1 pneumonia AU - Kiruchennanresultingfrom H1N1 pneumonia AU - Kiruchennan
hemodynamic derangementcan causehemodynamic derangement
ventilator - induced lung injury and improve survivalmay preventventilator - induced lung injury and improve survival
to a decrease in mortalityleadsto a decrease in mortality
significant morbidity and mortalitycausessignificant morbidity and mortality
fluid to leak into the lungscausesfluid to leak into the lungs
from viral and bacterial pneumonitis ( using venovenous ECMOresultingfrom viral and bacterial pneumonitis ( using venovenous ECMO
the complications(passive) caused bythe complications
metabolic acid - base adaptation(passive) is triggered bymetabolic acid - base adaptation
endotracheal tubes(passive) caused byendotracheal tubes